Mr. Gorevic is chief executive officer of Teladoc Health and has been a member of the board of directors since June 2009.
Prior to joining Teladoc Health, Mr. Gorevic served in various management roles at WellPoint, Inc. (now Anthem, Inc.), including president of Empire BlueCross BlueShield and senior vice president and chief sales and product officer.
From 2002 to 2005, Mr. Gorevic was a member of Empire BlueCross BlueShield’s leadership team, as chief sales and marketing officer. From July 2000 to December 2001, Mr. Gorevic served as chief executive officer of Gemfinity, an electronic marketplace and purchasing aggregator that he founded. From July 1999 to July 2000, he served as general manager of business messaging at Mail.com, Inc., a provider of internet messaging services, and from April 1998 to June 1999, he served as Mail.com’s vice president of operations.
Mr. Gorevic is a nationally recognized thought leader and trailblazer in virtual healthcare delivery. Prior to joining Teladoc Health, he held various executive leadership roles at WellPoint, Inc. (now Anthem, Inc.), Empire BlueCross BlueShield, Oxford Health, Mail.com, and Gemfinity.
He is a member of the board of directors of the New York Road Runners and serves on its youth and community service committee.
Mr. Snow became a member of the Teladoc Health board of directors in February 2014 and later was named chairman of our board in December 2014.
Since February 2014, Mr. Snow has served as chairman and chief executive officer of Cedar Gate Technologies, Inc., a provider of analytic and information technology services to providers, payers and self-insured employers entering risk-based/value-based care reimbursement arrangements. Until April 2012, Mr. Snow was chairman and chief executive officer of Medco Health Solutions, Inc., a leading pharmacy benefits manager. His current board service includes Premise Health since 2019. He formerly served as a director of Medco Health Solutions, Inc., CareCentrix and Pitney Bowes.
In addition to his experience as the chief executive officer of a public company, Mr. Snow has a strong background in operations, having served in leadership positions at several companies, including WellChoice (Empire BlueCross BlueShield) and Oxford Health Plans. Mr. Snow earned a B.S. in economics from Bates College and a master’s degree in healthcare administration from Duke University.
Mr. Bischoff became a member of the Teladoc Health board of directors in November 2020.
In May 2021, Mr. Bischoff will join General Catalyst as a managing director, where he will co-lead their teams in healthcare and in Europe. Mr. Bischoff is currently senior investment director of Kinnevik, a leading European investment company with over $12 billion in assets. Mr. Bischoff leads the investment team, overseeing all the sectors, with a focus on healthcare transformation in Europe and the U.S.
Mr. Bischoff also serves on the board of Cityblock Health and VillageMD. He previously served as a director of Livongo Health, Inc., until the merger with Teladoc Health in October 2020, as well as Avito, Babylon Health, Betterment and Cedar Cares.
Before joining Kinnevik in 2013, Mr. Bischoff was a managing director of Goldman Sachs in Europe, where he led the media and technology investment banking team. He holds a B.A. in history from the University of Bristol and an MBA from INSEAD.
Ms. Daniel became a member of the Teladoc Health board of directors in November 2020.
Ms. Daniel retired in July 2018 as executive director, division president and chief financial officer of the Global Finance and Technology Solutions division for Black & Veatch, a global leader in providing engineering, consulting and construction services for energy, water and telecommunication sectors.
As CFO, she was responsible for leading the company’s global financial operations that included treasury, tax, accounting, financial reporting, budgeting and financial systems, and establishing corporate financial policies. Ms. Daniel also led the company’s global IT organization, which included oversight of systems, technology development and associated service providers.
Ms. Daniel currently serves on the boards of directors of publicly traded Commerce Bancshares, Inc., and Snap-On Incorporated and previously served as a director of Livongo until the merger with Teladoc Health in October 2020. In 2020, she completed a three-year term on the board of Blue Cross and Blue Shield of Kansas City. She is also the past chairwoman of the Greater Kansas City Chamber of Commerce. She holds a Bachelor of Science degree in accounting from Northwest Missouri State University and a Master of Science degree in accounting from the University of Missouri-Kansas City.
Ms. Sandra Fenwick became a member of the Teladoc Health board of directors in November 2020.
Ms. Fenwick retired in March 2021 as chief executive officer of Boston Children’s Hospital, where she led the nation’s foremost independent pediatric hospital and the world’s leading center of pediatric medical and health research. She has been a driving force to improve the effectiveness and efficacy of the care provided at Boston Children’s while at the same time reducing the cost of care. Ms. Fenwick joined Boston Children’s in 1999 as senior vice president and was appointed chief operating officer that year. She was named president in 2008 and was appointed chief executive officer in 2013.
Ms. Fenwick currently serves on the boards of directors of Harvard’s Wyss Institute for Biologically Inspired Engineering, Risk Management Foundation of the Harvard Medical Institutions, Inc., and BCH Foundation UK Limited. Ms. Fenwick previously served as a director of Livongo until the merger with Teladoc Health in October 2020. She is also a member of the Massachusetts Women’s Forum and Women Corporate Directors Boston. She holds a bachelor’s degree from Simmons University with distinction and a master’s in public health degree in health services administration from the University of Texas School of Public Health. She has received numerous awards and honorary degrees for her contributions to healthcare.
Dr. Frist became a member of the Teladoc Health board of directors in September 2014.
Since 2007, Dr. Frist has served as a special partner in Cressey & Company, a private investment firm focused exclusively on investing in and building leading healthcare businesses. He is chairman of the Cressey Distinguished Executives Council. Senator Frist is also a partner at Frist Cressey Ventures, a venture capital firm specializing in healthcare investments. As a U.S. Senator, Dr. Frist represented Tennessee for 12 years, where he served on both the Finance and Health, Education, Labor and Pensions (HELP) committees responsible for writing all health legislation. He served as U.S. Senate majority leader from 2003 to 2007.
Prior to the Senate, Dr. Frist spent 20 years in clinical medicine, completing surgical training at Harvard Massachusetts General Hospital and Stanford, and he subsequently founded the Vanderbilt Transplant Center. Dr. Frist serves as an adjunct professor of cardiac surgery at Vanderbilt University. His previous board service includes Princeton University and the Smithsonian Institution.
Dr. Frist currently serves as a director of the publicly traded companies Select Medical, SmileDirectClub, Accolade, and GS Acquisitions Holdings Corp. II. In addition, he serves on the boards of Aegis Sciences Corporation, MDSave and Devoted Health. He previously served as a director of AECOM from 2014 to 2020, URS Corporation from November 2009 to 2014, and on the board of Third National Bank from 1990 to 1994.
His current board service includes the Robert Wood Johnson Foundation, The Nature Conservancy, NashvilleHealth and Tennessee’s State Collaborative on Education (SCORE). Dr. Frist earned his B.A. from Princeton University and MD from Harvard Medical School.
Ms. Jacobson became a member of the Teladoc Health board of directors in February 2020. Ms. Jacobson is president, CEO and a director of Froedtert Health, a regional healthcare system based in Milwaukee, Wisconsin. Before joining Froedtert Health in 2010, Ms. Jacobson spent 22 years at Rush University Medical Center in Chicago in various executive leadership roles, leaving the corporation as chief financial officer, treasurer and SVP of finance and strategic planning, marketing and communication.
A former board member and national chair of the Healthcare Financial Management Association, Ms. Jacobson is also an active member of the American College of Healthcare Executives and the American Healthcare Institute, and previously served as chair of the board of the Wisconsin Hospital Association.
Modern Healthcare recognized Ms. Jacobson in 2019 as one of the 100 Most Influential People in Healthcare and in 2021 as one of the Top 25 Women Leaders, while Junior Achievement of Wisconsin named her one of its 2018 Distinguished Executives of the Year, inducting her into the Wisconsin Business Hall of Fame. A graduate of Bradley University, Ms. Jacobson was recently awarded the honorary degree of doctor of healthcare leadership from the University of Wisconsin-Milwaukee.
Mr. McKinley became a member of the Teladoc Health board of directors in November 2009.
Mr. McKinley, who has more than 35 years of investment experience, is a general partner and the
West Coast representative for Cardinal Partners, a venture-capital firm focused exclusively on healthcare investing. Prior to joining Cardinal, Mr. McKinley was the co-founder and co-managing partner of Partech Partners. Mr. McKinley currently serves on the board of directors of Life Image, Inc., a cloud-based medical imaging sharing platform for hospitals, physicians and patients, and of Sapphire Digital, a transparency tool to reduce medical costs. Mr. McKinley is the chairman of the board of Prealize (formerly Cardinal Analytx), a software startup spun out of Stanford University that was created to identify and target high-cost patients for early medical interventions.
In addition, Mr. McKinley is the founding CEO and board member of Project Connect, a startup focused on improving bidirectional interoperability between providers and payers. Mr. McKinley earned an undergraduate degree in economics from Harvard University, an M.S. in accounting from New York University and an MBA from the Stanford Graduate School of Business.
Mr. Paulus became a member of the Teladoc Health board of directors in February 2017.
Mr. Paulus is currently the president and CEO and a director of Prime Therapeutics, one of the nation’s largest pharmacy benefit managers. From 2009 to 2014, Mr. Paulus was president and CEO of Allina Health, one of the nation’s largest not-for-profit integrated delivery systems. Prior to his appointment as CEO, he served as president and chief operating officer of Allina Health. Before joining Allina, Mr. Paulus was the president and CEO of Atrius Health, one of the largest integrated physician organizations in New England and a teaching and research affiliate of Harvard Medical School. He also served as the chief operating officer of Boston-based Partners HealthCare (now Mass General Brigham), a teaching affiliate of Harvard Medical School that includes Massachusetts General Hospital and Brigham and Women’s Hospital.
Mr. Paulus currently serves on the boards of AllyAlign Health and Breg, Inc. Previously, he sat on the boards of publicly traded companies Cogentix Medical and TeamHealth. Mr. Paulus received his master of healthcare administration and management from the University of Minnesota and a Bachelor of Arts in biology from Augustana College.
Mr. Shedlarz became a member of the Teladoc Health board of directors in September 2016.
He is the former vice chairman, executive vice president and chief financial officer of Pfizer, Inc., having had worldwide responsibility for the company’s former Medical Technology Group. During his 31-year tenure at Pfizer, Mr. Shedlarz played a key role in shaping the strategic direction that drove the company’s impressive growth and helped establish it as an industry leader and innovator. Among his senior leadership roles were that of executive vice president beginning in 1999 and then vice chairman in 2005, serving until his retirement in 2007.
Mr. Shedlarz sits on the boards of publicly traded The Hershey Company and Pitney Bowes, Inc. He holds a Master of Business Administration in finance and accounting from New York University Leonard N. Stern School of Business and a Bachelor of Science in economics and mathematics from Oakland University.
Dr. Smith became a member of the Teladoc Health board of directors in October 2018.
Dr. Smith is a professor of clinical medicine at the University of California at San Francisco. He is a board-certified internist and maintains a clinical practice in HIV care at San Francisco General Hospital. A nationally recognized care delivery and health policy expert, Dr. Smith co-chaired the Guiding Committee of the Health Care Payment Learning & Action Network, a public-private partnership launched by the U.S. Department of Health and Human Services to promote the transition to value-based payment to improve care quality while lowering costs.
From 1996 to 2013, Dr. Smith served as the founding president and CEO of the California Health Care Foundation, an independently endowed philanthropic organization that works to improve healthcare access and quality for Californians. He helped build the foundation into a recognized leader in delivery system innovation, public reporting of care quality and applications of new technology in healthcare.
Dr. Smith was formerly executive vice president of The Henry J. Kaiser Family Foundation. He was elected to the National Academy of Medicine in 2001 and chaired its committee on the Learning Healthcare System. Dr. Smith sits on the boards of publicly traded Jazz Pharmaceuticals PLC and Phreesia, Inc. He also serves on the boards of the Institute for Healthcare Improvement and the Commonwealth Fund and is on the editorial board of Health Affairs. Dr. Smith received a bachelor’s degree in Afro-American studies from Harvard College, a medical doctorate from the University of North Carolina at Chapel Hill and a master’s degree in business with a concentration in healthcare administration from the Wharton School at the University of Pennsylvania.
Taneja became a member of the Teladoc Health board of directors in November 2020.
Mr. Taneja is a managing director at General Catalyst. He joined the firm in 2001 and launched its Silicon Valley office in 2011. Hemant’s investment thesis, known as “economies of unscale,” describes the belief that small, tightly focused companies can leverage web services, datasets, and AI to successfully launch and compete against much larger, more established competitors.
His current investment portfolio ranges across several industries and includes companies such as Anduril, Applied Intuition, Color, Fundbox, Grammarly, Gusto, Livongo, Samsara, Snap, Stripe, and ThoughtSpot. In addition to his investments, Mr. Taneja serves on the Stanford School of Medicine Board of Fellows, is the co-founder of Advanced Energy Economy, an
organization focused on transforming energy policy in America and is a board member of Khan Lab School, a non-profit educational organization.
He teaches a course on AI, Entrepreneurship and Society at Stanford University and is a published author of two books, UnHealthcare: A Manifesto for Health Assurance and Unscaled: How AI and a New Generation of Upstarts Are Creating the Economy of the Future.
Mr. Glen Tullman became a member of the Teladoc Health board of directors in November 2020.
Mr. Tullman is the founder, former executive chairman and chief executive officer of Livongo Health. In his final year, he led Livongo through the largest consumer digital health initial public offering in history, a secondary offering, a convertible debt offering that raised over $550 million, and the industry’s largest merger to date between Livongo and Teladoc Health. He is also a founding partner at 7wireVentures, one of the highest-returning venture capital funds in Illinois.
Previously, Mr. Tullman was chief executive officer of Allscripts, the leading provider of electronic prescribing, practice management and electronic health records. He led the Allscripts IPO and secondary offering.
Mr. Tullman is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until these cures are found. In 2019, he was honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy and efficiency of our healthcare system. Mr. Tullman serves as a chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a board member of the American Diabetes Association. He has three amazing children that inspire him every day.